OS Therapies NYSE American: OSTX
@ostherapies.com
The leading Osteosarcoma technology company focused on the development and commercialization of treatments for Osteosarcoma. NYSE: $OSTX
OS Therapies NYSE American: OSTX's Company Logos
OS Therapies NYSE American: OSTX's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#33A7B5
Pelorous
51, 167, 181
186, 56, 45
72, 8, 0, 29
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#2B4B66
San Juan
43, 75, 102
207, 41, 28
58, 26, 0, 60
About OS Therapies NYSE American: OSTX
Discover OS Therapies, a brand dedicated to offering a range of holistic treatments that aim to balance the mind, body, and spirit for optimal health and well-being. With a focus on addressing the unmet medical needs of both kids and adults, OS Therapies specializes in targeting osteosarcoma (OS) and other solid tumors. Osteosarcoma, a challenging and aggressive form of bone cancer, has lacked new treatments for over three decades.
Here at OS Therapies, we strive to answer this call by developing innovative therapies. We have expanded our pipeline to include OST-HER2, a potential treatment for breast, esophageal, and lung cancer, as well as OST-TDC, a next-generation Antibody Drug Conjugate platform technology targeting ovarian, lung, and pancreatic cancer. Our goal is to identify and develop lead candidates for clinical development, regulatory approval, and commercialization.
Join us on our mission to transform the treatment landscape for osteosarcoma and other solid tumors
Company type
Privately Held
Year founded
2018
Company size
2-10 employees
Related Brands
Tags
Cancer immunotherapy
HER2-targeted therapies
Osteosarcoma treatment
Antibody-drug conjugates
Clinical-stage oncology research
